Most Read Articles
6 days ago
Girls with eosinophilic oesophagitis (EoE) who show initial response to directed therapy will tend to continue to respond well to treatment, a recent study has shown.
Pearl Toh, 4 days ago
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
Elvira Manzano, 5 days ago
Final overall survival (OS) results from the double-blind phase III FLAURA study reinforce osimertinib as the standard frontline treatment for epidermal growth factor receptor-mutated (EGFRm) non–small cell lung cancer (NSCLC), say leading oncologists at ESMO 2019.
Tristan Manalac, 4 days ago
Babies born to mothers exposed to high levels of bisphenol A during pregnancy are at a greater risk of wheezing and poor lung function, according to a new study presented at the recently concluded International Congress of the European Respiratory Society (ERS 2019).

Meal timing helps suppress appetite

Tristan Manalac
03 Aug 2019
Surviving without food: Is it possible?

Restricting the timing of food intake facilitates weight loss not by altering energy expenditure but by regulating appetite, according to a recent study.

“Aligning food intake with circadian rhythms may therefore be a powerful strategy for reducing appetite and losing weight,” said researchers. “The subset of meal-timing interventions that involve intermittent fasting, such as time-restricted feeding, may confer additional metabolic advantages by improving metabolic flexibility and increasing 24-hour fat oxidation.”

Eleven overweight adults (mean age, 32±7 years; seven males) were included in the randomized, crossover, isocaloric, controlled feeding trial. After the early time-restricted feeding (eTRF) condition, appetite between 11:00 AM and 5:00 PM was significantly suppressed (p0.05), while all five indicators were increased at bedtime (10:30 PM; p0.007). [Obesity 2019;doi:10.1002/oby.22518]

The five appetite indicators used were hunger, desire to eat, capacity to eat, fullness and stomach fullness. None were significantly altered by eTRF at breakfast (8:00 AM; p=0.09 for capacity to eat, p0.39 for the other) or in the middle of the evening (8:00 PM; p0.27).

Overall, the eTRF regimen suppressed the daily amplitudes in hunger (change, –10±3 mm; p=0.006) and desire to eat (change, –9±5; p=0.09), while also reducing the mean desire to eat (change, 5±2 mm; p=0.08) and increasing mean stomach fullness (change, 3±2 mm; p=0.06) and fullness (change, 3±2 mm; p=0.10).

At the same time, eTRF elicited a significant dip in morning concentrations of active ghrelin (change, –43±15 pg/mL; p=0.009), leptin (change, –4±1 ng/mL; p=0.01) and glucagon-like peptide 1 (change, –0.8±0.3 pmol/mL; p=0.008). Ghrelin was likewise reduced during evenings (change, –22±12 pg/mL; p=0.09) while peptide YY3-36  levels were increased (PYY; change, 17±6 pg/mL; p=0.02).

“We found that eTRF lowered mean values of the hunger hormone ghrelin (mostly in the morning) as well as increased levels of the satiety hormone PYY in the middle of the evening,” corroborating the patterns obtained when using appetite indicators, said researchers.

“Surprisingly and paradoxically, eTRF reduced swings in hunger (i.e., reduced the diurnal amplitude of hunger), making hunger levels more even-keeled throughout the day, which may reduce overeating or binge eating,” they noted.

Despite such changes in appetite and satiety markers, researchers observed no significant effect of eTRF on energy expenditure. While there was a daytime excess in energy expenditure after food restriction (change, 56±15 kcal per 12 hours; p=0.003), this was offset by a drop in expenditure during nighttime (change, –46±6 kcal per 12 hours; p<0.0001).

Overall, the net effect of eTRF on energy expenditure failed to reach statistical significance (p=0.55).

“[O]ur data suggest that meal-timing interventions facilitate weight loss primarily by suppressing appetite,” said researchers. “Although we were not powered to detect differences in 24-hour energy expenditure as small as approximately 20 to 40 kcal/d, such small differences are considered clinically insignificant.”

“Further research is needed to determine the effects of meal timing on energy and fat metabolism,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Girls with eosinophilic oesophagitis (EoE) who show initial response to directed therapy will tend to continue to respond well to treatment, a recent study has shown.
Pearl Toh, 4 days ago
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
Elvira Manzano, 5 days ago
Final overall survival (OS) results from the double-blind phase III FLAURA study reinforce osimertinib as the standard frontline treatment for epidermal growth factor receptor-mutated (EGFRm) non–small cell lung cancer (NSCLC), say leading oncologists at ESMO 2019.
Tristan Manalac, 4 days ago
Babies born to mothers exposed to high levels of bisphenol A during pregnancy are at a greater risk of wheezing and poor lung function, according to a new study presented at the recently concluded International Congress of the European Respiratory Society (ERS 2019).